JD Health International Inc.
6618
Classement en actions
#1391
JD Health International Inc., functioning as an investment holding entity, runs... JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products, such as over-the-counter and prescription medications, medical devices, and health supplements. These goods are distributed through both direct sales and an extensive online retail pharmacy network. Beyond product offerings, its comprehensive service suite includes virtual medical consultations, patient referrals to hospitals and doctors, health screening programs, genetic testing, and beauty care services. Additionally, it develops intelligent healthcare and wellness management solutions, alongside providing technical support and advertising services. The platform also facilitates access to various medical provisions, including general health examinations, cosmetic medical procedures, vaccination bookings, dental treatments, and nucleic acid testing. Incorporated in 2018 and headquartered in Beijing, People's Republic of China, JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Prix de l'action
$4.96
Capitalisation boursière
$15.82B
Changement (1 jour)
-2.58%
Changement (1 an)
-40.00%
Pays
CN
Échange JD Health International Inc. (6618)
Catégorie
Healthcare
Bénéfices pour JD Health International Inc. (6618)
Bénéfices en Jun 2026 TTM : $1.07B
Selon les derniers rapports financiers de JD Health International Inc., les bénéfices actuels de l'entreprise sont de $1.07B. En 2023, l'entreprise a réalisé un bénéfice de $380.49M, une augmentation par rapport à celui de 2022 qui était de $100.87M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour JD Health International Inc. de 2017 à 2026
Bénéfices à la fin de chaque année
| Année | Bénéfices | Changez |
|---|---|---|
| 2026 (TTM) | $1.07B | 62.26% |
| 2024 | $657.16M | 72.71% |
| 2023 | $380.49M | 277.20% |
| 2022 | $100.87M | -171.12% |
| 2021 | $-141.84M | -94.57% |
| 2020 | $-2.61B | 2,080.12% |
| 2019 | $-119.87M | -369.26% |
| 2018 | $44.52M | 13.15% |
| 2017 | $39.34M | 0.00% |
Bénéfices des entreprises similaires ou concurrentes
| Entreprise | Bénéfices | Différence de bénéfices | Pays |
|---|---|---|---|
| $9.87B | 825.69% |
US
|
|
| - | - |
DE
|
|
| $3.87B | 262.46% |
US
|
|
| $687.82M | -35.50% |
SA
|
|
| $1.25B | 16.92% |
BR
|
